Michael D. Jones

This paper identifies a sulfinyl aziridine compound that selectively degrades MYC by targeting specific residues in its intrinsically disordered regions, demonstrating the potential of chiral small molecules for targeting undruggable proteins.

The paper introduces two methods to correct false positives in CRISPR screens caused by copy number variations, reducing false positives by 70-80% in amplified regions.